How is Europe's opioid market evolving? What substances are causing the most concern today? How are countries responding to cannabis use? Find out more when the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) launches its European Drug Report 2024: Trends and Developments in a live online press conference on 11 June.
Based on data from 29 countries (EU 27, Türkiye and Norway), the online report delivers the latest overview of the drug situation in Europe, exploring long-term trends and emerging threats. The comprehensive analysis covers drug use and supply as well as drug-related harms and responses to them.
Over 100 interactive graphics complement the analysis, while dedicated interactive dashboards allow users to visualise data and trends at European and national level. Data journalists and researchers will be able to access the source data for easier sharing and re-use. The resource is designed to be read across a range of devices (PCs, mobiles, tablets).
Accompanying the report is the 2024 Statistical Bulletin containing national datasets.
Join us for the live online event to hear about the key issues and latest analysis.
Press conference (online)
Date: 11 June 2024 at 10.00 WEST (Lisbon), 11.00 CEST (Brussels)
Speakers:
- Ylva Johansson, European Commissioner for Home Affairs
- Franz Pietsch, Chair of the EMCDDA Management Board (Austria)
- Alexis Goosdeel, EMCDDA Director
Further details will be available in the run-up to the launch on the European Drug Report 2024 launch event page.
Embargoed report and interviews: press@emcdda.europa.eu
The press conference will be conducted in English.
